A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran
Letters in Applied Microbiology · 2025
DOI: 10.1093/lambio/ovaf111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2025. Verfasst von Samira Saedi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Bacteria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Immunology Research Center, Tabriz University of Medical Sciences.
Abstract (Originalsprache)
The gut microbiota, which plays a vital role in synthesizing short-chain fatty acids (SCFAs), is involved in the pathogenesis of inflammatory bowel disease (IBD). This study aimed to evaluate four phyla of gut microbiota and main SCFAs in IBD patients compared to the control group. Stool samples from 40 IBD patients [including ulcerative colitis (UC) and Crohn's disease (CD)] and 20 healthy controls were analyzed. Quantitative polymerase chain reaction was used to assess the abundance of four major gut microbiota phyla, and SCFA concentrations were measured using high-performance liquid chromatography. Results showed that Firmicutes levels were significantly lower in both UC and CD patients compared to controls. Bacteroidetes were significantly reduced in CD patients, while proteobacteria were significantly elevated in UC patients. No significant differences were observed in Actinobacteria levels. Regarding SCFAs, butyric acid was significantly lower in both UC and CD patients. Additionally, acetic acid and propionic acid were significantly decreased only in UC patients. These findings highlight the presence of gut dysbiosis and altered SCFA profiles in IBD patients. Given the protective roles of gut microbiota and their metabolites, strategies to restore microbial balance and SCFA production may support the management and treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Environmental Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj 66177113446, Iran.
- Department of Internal Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran.
ORCID-Profile: Alka Hasani
Förderung
- Immunology Research Center
- Tabriz University of Medical Sciences
Zitieren
APA
Saedi, S., Derakhshan, S., Sadeghi, J., Hasani, A., Khoshbaten, M., Poortahmasebi, V., & Ahmadi, S. (2025). A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovaf111
Vancouver
Saedi S, Derakhshan S, Sadeghi J, Hasani A, Khoshbaten M, Poortahmasebi V, et al. A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran. Letters in Applied Microbiology. 2025. doi:10.1093/lambio/ovaf111
BibTeX
@article{Saedi2025,
author = {Saedi, Samira and Derakhshan, Safoura and Sadeghi, Javid and Hasani, Alka and Khoshbaten, Manouchehr and Poortahmasebi, Vahdat and Ahmadi, Somayeh},
title = {A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran},
journal = {Letters in Applied Microbiology},
year = {2025},
doi = {10.1093/lambio/ovaf111}
}
EUVIMED